Huong D. Meeks

Huong D. Meeks, MPH, MStat, PhD

Languages spoken: English, Vietnamese

Academic Information

Departments Primary - Pediatrics

Divisions: Critical Care

Dr. Meeks (she/her) is an Assistant Professor in the Department of Pediatrics, Critical Care Division and a faculty epidemiologist at the University of Utah Data Coordinating Center. She earned both her PhD and MPH in Epidemiology, as well as an MS in Statistics from Utah State University and completed her postdoctoral fellowship at the Huntsman Cancer Institute. Prior to her faculty position, she worked as a biostatistician at the Pedigree and Population Resources where she collaborated with researchers across multiple disciplines including obstetrics/gynecology, oncology, urology, nutrition, neuropsychology, among others. Her research focuses on statistical methodologies for observational studies, particularly those leveraging registry data and electronic health records. She has specialized expertise in developing longitudinal databases that integrate and harmonize measures of individual and neighborhood socioeconomic characteristics over multiple decades. She is especially interested in how family and neighborhood environments promote individual well-being across the life course, with particular emphasis on the impact of family caregiving and neighborhood disparities on adverse pediatric health outcomes. Dr. Meeks is a core member of the Energy Balance Research Group, a member of the University of Utah Resource for Genetic & Epidemiologic Research, a caregiving scholar within the Family Caregiving Collaborative, and an affiliated member of the Consortium for Families and Health Research.

Education History

Graduate Training Utah State University
 MStat
Graduate Training Utah State University
 PhD
Graduate Training Utah State University
 MS
Undergraduate Brigham Young University–Idaho
 BS

Selected Publications

Journal Article

  1. Kole K, Zick CD, Brown BB, Curtis DS, Kowaleski-Jones L, Meeks HD, Smith KR (2024). Instrumental variables in the cost of illness featuring type 2 diabetes. Health Serv Res, 60(3), e14412. (Read full article)
  2. Iacob E, Hollingshaus M, Utz RL, Tay DL, Ornstein KA, Alexander R, Barrientos P, Ellington L, Newman M, Belnap T, Cizik AM, Smith KR, Meeks HD, Stephens CE (2025). Caregiving at end-of-life: How do family structure and dementia status impact antidepressant and anxiolytic prescriptions among families? Alzheimers Dement, 21(6), e14590. (Read full article)
  3. Songer KL, Wawrzynski SE, Olson LM, Harousseau ME, Meeks HD, Moresco BL, Delgado-Corcoran C (2025). Association of Palliative Care Timing With End-of-Life Quality in Children With Heart Disease. J Pain Symptom Manage, 69(4), 402-408. (Read full article)
  4. Meeks HD, Yu DZ, Fraser A, Maloney TN, Curtin K, Newman M, Smith KR (2025). Utilize administrative data to assess impact of individual-level and neighborhood-level socioeconomic status on childhood health in a longitudinal study. Public Health, 240, 154-160. (Read full article)
  5. Songer KL, Wawrzynski SE, Olson LM, Harousseau ME, Meeks HD, Moresco BL, Delgado-Corcoran C (2024). Timing of Palliative Care Consultation and End-of-Life Care Intensity in Pediatric Patients With Advanced Heart Disease: Single-Center, Retrospective Cohort Study, 2014-2022. Pediatr Crit Care Med, 26(1), e23-e32. (Read full article)
  6. Aronson PL, Kuppermann N, Mahajan P, Nielsen B, Olsen CS, Meeks HD, Grundmeier RW, PECARN Registry Working Group (2024). Natural Language Processing to Identify Infants Aged 90 Days and Younger With Fevers Prior to Presentation. Hosp Pediatr, 15(1), e1-e5. (Read full article)
  7. Ross R, ONeill KA, Betensky RA, Billiet T, Kenney R, Lovett JT, Maletic-Savatic M, Meeks HD, Sosa A, Waltz M, Krupp LB (2024). Association of Social Determinants of Health With Brain MRI Outcomes in Individuals With Pediatric Onset Multiple Sclerosis. Neurology, 103(12), e210140. (Read full article)
  8. Wilson E, Meeks HD, Barney BJ, Waltz M, Canenguez K, Casper TC, Rose JW, Rodriguez M, Tillema JM, Chitnis T, Gorman MP, Rensel M, Abrams AW, Krupp LB, Lotze TE, Fisher KS, Shukla NM, Schreiner TL, Mar SS, Waubant E, Virupakshaiah A, Wheeler YS, Ness JM, Benson LA, as the United States Network of Pediatric Multiple Sclerosis Centers (2024). Epidemiology and Impact of Social Hardships in Children With Multiple Sclerosis in the United States. Neurology, 103(11), e209991. (Read full article)
  9. Barnard ME, Farland LV, Yan B, Wang J, Trabert B, Doherty JA, Meeks HD, Madsen M, Guinto E, Collin LJ, Maurer KA, Page JM, Kiser AC, Varner MW, Allen-Brady K, Pollack AZ, Peterson KR, Peterson CM, Schliep KC (2024). Endometriosis Typology and Ovarian Cancer Risk. JAMA, 332(6), 482-489. (Read full article)
  10. Peckham ME, Shah LM, Meeks HD, Fraser A, Galvao C, Safazadeh G, Hutchins TA, Anzai Y, Fritz JM, Kean J, Carlos RC (2024). Disparities in Provider Ordering Practices of Image-Guided Interventions and Surgery for Patients With Low Back Pain: A Cohort Study. J Am Coll Radiol, 21(7), 1010-1023. (Read full article)
  11. Curtis DS, Kole K, Brown BB, Smith KR, Meeks HD, Kowaleski-Jones L (2023). Social inequities in neighborhood health amenities over time in the Wasatch Front Region of Utah: Historical inequities, population selection, or differential investment? Cities, 145. (Read full article)
  12. ONeill DC, Steffenson LN, Myhre LA, Kantor AH, Meeks HD, Fraser AM, Marchand LS, Haller JM (2023). Analysis of acute extremity compartment syndrome using a genealogic population database. Arch Orthop Trauma Surg, 144(1), 149-160. (Read full article)
  13. Kantor AH, ONeill DC, Steffenson LN, Meeks HD, Fraser AM, Marchand LM, Haller JM (2023). Familial Analysis of Nonunion in a Genealogic Population Database Demonstrates No Evidence of Heritable Risk. J Orthop Trauma, 37(11), 591-598. (Read full article)
  14. Gavile CM, Kazmers NH, Novak KA, Meeks HD, Yu Z, Thomas JL, Hansen C, Barker T, Jurynec MJ (2022). Familial Clustering and Genetic Analysis of Severe Thumb Carpometacarpal Joint Osteoarthritis in a Large Statewide Cohort. J Hand Surg Am, 47(10), 923-933. (Read full article)
  15. Gill AS, Meeks H, Curtin K, Alt JA (2022). Tobacco Use Increases the Adjusted Risk of Revision Endoscopic Sinus Surgery in Patients With Chronic Rhinosinusitis. Am J Rhinol Allergy, 36(6), 19458924221105926. (Read full article)
  16. Barnard ME, Meeks H, Jarboe EA, Albro J, Camp NJ, Doherty JA (2022). Familial risk of epithelial ovarian cancer after accounting for gynaecological surgery: a population-based study. J Med Genet, 60(2), 119-127. (Read full article)
  17. Tay DL, Ornstein KA, Meeks H, Utz RL, Smith KR, Stephens C, Hashibe M, Ellington L (2021). Evaluation of Family Characteristics and Multiple Hospitalizations at the End of Life: Evidence from the Utah Population Database. J Palliat Med, 25(3), 376-387. (Read full article)
  18. Smith KA, Gill AS, Beswick DM, Meeks H, Oakley GM, Yim M, Curtin K, Orlandi RR, Alt JA (2021). Cystic Fibrosis Increases Long-Term Revision Rates of Endoscopic Sinus Surgery in Patients With Comorbid Chronic Rhinosinusitis. Am J Rhinol Allergy, 36(2), 222-228. (Read full article)
  19. Patel DP, Meeks HT, Pastuszak AW, Hanson HA, Smith KR, Letourneau JM, Hotaling JM (2021). Lower female partner live birth rate in male cancer survivors: An age-matched cohort analysis of the Utah Population Database. Andrologia, 54(1), e14293. (Read full article)
  20. Garg D, Meeks HD, Johnstone E, Berga SL, Smith KR, Hotaling J, Letourneau JM (2021). Cancer treatment is associated with a measurable decrease in live births in a large, population-based study. F S Rep, 2(4), 462-467. (Read full article)
  21. Gill AS, Smith KA, Meeks H, Oakley GM, Curtin K, LeClair L, Howe H, Orlandi RR, Alt JA (2021). Asthma increases long-term revision rates of endoscopic sinus surgery in chronic rhinosinusitis with and without nasal polyposis. Int Forum Allergy Rhinol, 11(8), 1197-1206. (Read full article)
  22. Schacht R, Meeks H, Fraser A, Smith KR (2021). Was Cinderella just a fairy tale? Survival differences between stepchildren and their half-siblings. Philos Trans R Soc Lond B Biol Sci, 376(1827), 20200032. (Read full article)
  23. Patel DP, Meeks HT, Hanson HA, Pastuszak AW, Hotaling JM, Smith KR (2021). Lower total motile count is associated with smaller historic intergenerational family size: a pedigree analysis from the Utah Population Database. J Assist Reprod Genet, 38(5), 1207-1213. (Read full article)
  24. Dude AM, Smid MC, Branch DW, West J, Meeks H, Yu Z, Fraser A, Smith K, Reddy D (2021). Interpregnancy Body Mass Index Change and Offspring Mortality Risk following the Second Pregnancy. Am J Perinatol, 40(4), 387-393. (Read full article)
  25. Kazmers NH, Meeks HD, Novak KA, Yu Z, Fulde GL, Thomas JL, Barker T, Jurynec MJ (2021). Familial Clustering of Erosive Hand Osteoarthritis in a Large Statewide Cohort. Arthritis Rheumatol, 73(3), 440-447. (Read full article)
  26. Schacht R, Macfarlan SJ, Meeks H, Cervantes PL, Morales F (2020). Male survival advantage on the Baja California peninsula. Biol Lett, 16(11), 20200600. (Read full article)
  27. DeKeyser GJ, Anderson MB, Meeks HD, Pelt CE, Peters CL, Gililland JM (2020). Socioeconomic Status May Not Be a Risk Factor for Periprosthetic Joint Infection. J Arthroplasty, 35(7), 1900-1905. (Read full article)
  28. Cawthon RM, Meeks HD, Sasani TA, Smith KR, Kerber RA, OBrien E, Baird L, Dixon MM, Peiffer AP, Leppert MF, Quinlan AR, Jorde LB (2020). Germline mutation rates in young adults predict longevity and reproductive lifespan. Sci Rep, 10(1), 10001. (Read full article)
  29. Hammad IA, Meeks H, Fraser A, Theilen LH, Esplin MS, Smith KR, Varner MW (2019). Risks of cause-specific mortality in offspring of pregnancies complicated by hypertensive disease of pregnancy. Am J Obstet Gynecol, 222(1), 75.e1-75.e9. (Read full article)
  30. Duensing I, Anderson MB, Meeks HD, Curtin K, Gililland JM (2019). Patients with Type-1 Diabetes Are at Greater Risk of Periprosthetic Joint Infection: A Population-Based, Retrospective, Cohort Study. J Bone Joint Surg Am, 101(20), 1860-1867. (Read full article)
  31. Hanson GR, McMillan S, Mower K, Bruett CT, Duarte L, Koduri S, Pinzon L, Warthen M, Smith K, Meeks H, Trump B (2019). Comprehensive oral care improves treatment outcomes in male and female patients with high-severity and chronic substance use disorders. J Am Dent Assoc, 150(7), 591-601. (Read full article)
  32. Smith KA, Orlandi RR, Oakley G, Meeks H, Curtin K, Alt JA (2018). Long-term revision rates for endoscopic sinus surgery. Int Forum Allergy Rhinol, 9(4), 402-408. (Read full article)
  33. Chernenko A, Meeks H, Smith KR (2019). Examining validity of body mass index calculated using height and weight data from the US driver license. BMC Public Health, 19(1), 100. (Read full article)
  34. Patel B, Meeks H, Wan Y, Johnstone EB, Glenn M, Smith KR, Hotaling JM (2018). Transgenerational effects of chemotherapy: Both male and female children born to women exposed to chemotherapy have fewer children. Cancer Epidemiol, 56, 1-5. (Read full article)
  35. Theilen LH, Meeks H, Fraser A, Esplin MS, Smith KR, Varner MW (2018). Long-term mortality risk and life expectancy following recurrent hypertensive disease of pregnancy. Am J Obstet Gynecol, 219(1), 107.e1-107.e6. (Read full article)
  36. Colombo M, Lpez-Perolio I, Meeks HD, Caleca L, Parsons MT, Li H, De Vecchi G, Tudini E, Foglia C, Mondini P, Manoukian S, Behar R, Garcia EBG, Meindl A, Montagna M, Niederacher D, Schmidt AY, Varesco L, Wappenschmidt B, Bolla MK, Dennis J, Michailidou K, Wang Q, Aittomki K, Andrulis IL, Anton-Culver H, Arndt V, Beckmann MW, Beeghly-Fadel A, Benitez J, Boeckx B, Bogdanova NV, Bojesen SE, Bonanni B, Brauch H, Brenner H, Burwinkel B, Chang-Claude J, Conroy DM, Couch FJ, Cox A, Cross SS, Czene K, Devilee P, Drk T, Eriksson M, Fasching PA, Figueroa J, Fletcher O, Flyger H, Gabrielson M, Garca-Closas M, Giles GG, Gonzlez-Neira A, Gunel P, Haiman CA, Hall P, Hamann U, Hartman M, Hauke J, Hollestelle A, Hopper JL, Jakubowska A, Jung A, Kosma VM, Lambrechts D, Le Marchand L, Lindblom A, Lubinski J, Mannermaa A, Margolin S, Miao H, Milne RL, Neuhausen SL, Nevanlinna H, Olson JE, Peterlongo P, Peto J, Pylks K, Sawyer EJ, Schmidt MK, Schmutzler RK, Schneeweiss A, Schoemaker MJ, See MH, Southey MC, Swerdlow A, Teo SH, Toland AE, Tomlinson I, Truong T, van Asperen CJ, van den Ouweland AMW, van der Kolk LE, Winqvist R, Yannoukakos D, Zheng W, kConFabAOCS Investigators, Dunning AM, Easton DF, Henderson A, Hogervorst FBL, Izatt L, Offitt K, Side LE, van Rensburg EJ, Embrace S, Hebon S, McGuffog L, Antoniou AC, Chenevix-Trench G, Spurdle AB, Goldgar DE, Hoya M, Radice P (2018). The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. Hum Mutat, 39(5), 729-741. (Read full article)
  37. Moghadasi S, Meeks HD, Vreeswijk MP, Janssen LA, Borg, Ehrencrona H, Paulsson-Karlsson Y, Wappenschmidt B, Engel C, Gehrig A, Arnold N, Hansen TVO, Thomassen M, Jensen UB, Kruse TA, Ejlertsen B, Gerdes AM, Pedersen IS, Caputo SM, Couch F, Hallberg EJ, van den Ouweland AM, Colle MJ, Teugels E, Adank MA, van der Luijt RB, Mensenkamp AR, Oosterwijk JC, Blok MJ, Janin N, Claes KB, Tucker K, Viassolo V, Toland AE, Eccles DE, Devilee P, Van Asperen CJ, Spurdle AB, Goldgar DE, Garca EG (2017). The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium. J Med Genet, 55(1), 15-20. (Read full article)
  38. Shimelis H, Mesman RLS, Von Nicolai C, Ehlen A, Guidugli L, Martin C, Callja FMGR, Meeks H, Hallberg E, Hinton J, Lilyquist J, Hu C, Aalfs CM, Aittomki K, Andrulis I, Anton-Culver H, Arndt V, Beckmann MW, Benitez J, Bogdanova NV, Bojesen SE, Bolla MK, Borresen-Dale AL, Brauch H, Brennan P, Brenner H, Broeks A, Brouwers B, Brning T, Burwinkel B, Chang-Claude J, Chenevix-Trench G, Cheng CY, Choi JY, Colle JM, Cox A, Cross SS, Czene K, Darabi H, Dennis J, Drk T, Dos-Santos-Silva I, Dunning AM, Fasching PA, Figueroa J, Flyger H, Garca-Closas M, Giles GG, Glendon G, Gunel P, Haiman CA, Hall P, Hamann U, Hartman M, Hogervorst FB, Hollestelle A, Hopper JL, Ito H, Jakubowska A, Kang D, Kosma VM, Kristensen V, Lai KN, Lambrechts D, Marchand LL, Li J, Lindblom A, Lophatananon A, Lubinski J, Machackova E, Mannermaa A, Margolin S, Marme F, Matsuo K, Miao H, Michailidou K, Milne RL, Muir K, Neuhausen SL, Nevanlinna H, Olson JE, Olswold C, Oosterwijk JJC, Osorio A, Peterlongo P, Peto J, Pharoah PDP, Pylks K, Radice P, Rashid MU, Rhenius V, Rudolph A, Sangrajrang S, Sawyer EJ, Schmidt MK, Schoemaker MJ, Seynaeve C, Shah M, Shen CY, Shrubsole M, Shu XO, Slager S, Southey MC, Stram DO, Swerdlow A, Teo SH, Tomlinson I, Torres D, Truong T, van Asperen CJ, van der Kolk LE, Wang Q, Winqvist R, Wu AH, Yu JC, Zheng W, Zheng Y, Leary J, Walker L, Foretova L, Fostira F, Claes KBM, Varesco L, Moghadasi S, Easton DF, Spurdle A, Devilee P, Vrieling H, Monteiro ANA, Goldgar DE, Carreira A, Vreeswijk MPG, Couch FJ, for kConFabAOCS Investigators, for NBCS Collaborators (2017). BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer. Cancer Res, 77(11), 2789-2799. (Read full article)
  39. de la Hoya M, Soukarieh O, Lpez-Perolio I, Vega A, Walker LC, van Ierland Y, Baralle D, Santamaria M, Lattimore V, Wijnen J, Whiley P, Blanco A, Raponi M, Hauke J, Wappenschmidt B, Becker A, Hansen TV, Behar R, Investigators K, Niederacher D, Arnold N, Dworniczak B, Steinemann D, Faust U, Rubinstein W, Hulick PJ, Houdayer C, Caputo SM, Castera L, Pesaran T, Chao E, Brewer C, Southey MC, van Asperen CJ, Singer CF, Sullivan J, Poplawski N, Mai P, Peto J, Johnson N, Burwinkel B, Surowy H, Bojesen SE, Flyger H, Lindblom A, Margolin S, Chang-Claude J, Rudolph A, Radice P, Galastri L, Olson JE, Hallberg E, Giles GG, Milne RL, Andrulis IL, Glendon G, Hall P, Czene K, Blows F, Shah M, Wang Q, Dennis J, Michailidou K, McGuffog L, Bolla MK, Antoniou AC, Easton DF, Couch FJ, Tavtigian S, Vreeswijk MP, Parsons M, Meeks HD, Martins A, Goldgar DE, Spurdle AB (2016). Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms. Hum Mol Genet, 25(11), 2256-2268. (Read full article)
  40. Li J, Meeks H, Feng BJ, Healey S, Thorne H, Makunin I, Ellis J, kConFab Investigators, Campbell I, Southey M, Mitchell G, Clouston D, Kirk J, Goldgar D, Chenevix-Trench G (2015). Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families. J Med Genet, 53(1), 34-42. (Read full article)
  41. Meeks HD, Song H, Michailidou K, Bolla MK, Dennis J, Wang Q, Barrowdale D, Frost D, EMBRACE, McGuffog L, Ellis S, Feng B, Buys SS, Hopper JL, Southey MC, Tesoriero A, kConFab Investigators, James PA, Bruinsma F, Campbell IG, Australia Ovarian Cancer Study Group, Broeks A, Schmidt MK, Hogervorst FB, HEBON, Beckman MW, Fasching PA, Fletcher O, Johnson N, Sawyer EJ, Riboli E, Banerjee S, Menon U, Tomlinson I, Burwinkel B, Hamann U, Marme F, Rudolph A, Janavicius R, Tihomirova L, Tung N, Garber J, Cramer D, Terry KL, Poole EM, Tworoger SS, Dorfling CM, van Rensburg EJ, Godwin AK, Gunel P, Truong T, GEMO Study Collaborators, Stoppa-Lyonnet D, Damiola F, Mazoyer S, Sinilnikova OM, Isaacs C, Maugard C, Bojesen SE, Flyger H, Gerdes AM, Hansen TV, Jensen A, Kjaer SK, Hogdall C, Hogdall E, Pedersen IS, Thomassen M, Benitez J, Gonzlez-Neira A, Osorio A, Hoya Mde L, Segura PP, Diez O, Lazaro C, Brunet J, Anton-Culver H, Eunjung L, John EM, Neuhausen SL, Ding YC, Castillo D, Weitzel JN, Ganz PA, Nussbaum RL, Chan SB, Karlan BY, Lester J, Wu A, Gayther S, Ramus SJ, Sieh W, Whittermore AS, Monteiro AN, Phelan CM, Terry MB, Piedmonte M, Offit K, Robson M, Levine D, Moysich KB, Cannioto R, Olson SH, Daly MB, Nathanson KL, Domchek SM, Lu KH, Liang D, Hildebrant MA, Ness R, Modugno F, Pearce L, Goodman MT, Thompson PJ, Brenner H, Butterbach K, Meindl A, Hahnen E, Wappenschmidt B, Brauch H, Brning T, Blomqvist C, Khan S, Nevanlinna H, Pelttari LM, Aittomki K, Butzow R, Bogdanova NV, Drk T, Lindblom A, Margolin S, Rantala J, Kosma VM, Mannermaa A, Lambrechts D, Neven P, Claes KB, Maerken TV, Chang-Claude J, Flesch-Janys D, Heitz F, Varon-Mateeva R, Peterlongo P, Radice P, Viel A, Barile M, Peissel B, Manoukian S, Montagna M, Oliani C, Peixoto A, Teixeira MR, Collavoli A, Hallberg E, Olson JE, Goode EL, Hart SN, Shimelis H, Cunningham JM, Giles GG, Milne RL, Healey S, Tucker K, Haiman CA, Henderson BE, Goldberg MS, Tischkowitz M, Simard J, Soucy P, Eccles DM, Le N, Borresen-Dale AL, Kristensen V, Salvesen HB, Bjorge L, Bandera EV, Risch H, Zheng W, Beeghly-Fadiel A, Cai H, Pylks K, Tollenaar RA, Ouweland AM, Andrulis IL, Knight JA, OCGN, Narod S, Devilee P, Winqvist R, Figueroa J, Greene MH, Mai PL, Loud JT, Garca-Closas M, Schoemaker MJ, Czene K, Darabi H, McNeish I, Siddiquil N, Glasspool R, Kwong A, Park SK, Teo SH, Yoon SY, Matsuo K, Hosono S, Woo YL, Gao YT, Foretova L, Singer CF, Rappaport-Feurhauser C, Friedman E, Laitman Y, Rennert G, Imyanitov EN, Hulick PJ, Olopade OI, Senter L, Olah E, Doherty JA, Schildkraut J, Koppert LB, Kiemeney LA, Massuger LF, Cook LS, Pejovic T, Li J, Borg A, fverholm A, Rossing MA, Wentzensen N, Henriksson K, Cox A, Cross SS, Pasini BJ, Shah M, Kabisch M, Torres D, Jakubowska A, Lubinski J, Gronwald J, Agnarsson BA, Kupryjanczyk J, Moes-Sosnowska J, Fostira F, Konstantopoulou I, Slager S, Jones M, PRostate cancer AssoCiation group To Investigate Cancer Associated aLterations in the genome, Antoniou AC, Berchuck A, Swerdlow A, Chenevix-Trench G, Dunning AM, Pharoah PD, Hall P, Easton DF, Couch FJ, Spurdle AB, Goldgar DE (2015). BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J Natl Cancer Inst, 108(2). (Read full article)